2012
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies.
Puda A,
Milosevic JD,
Berg T,
Klampfl T,
Harutyunyan AS,
Gisslinger B,
Rumi E,
Pietra D,
Malcovati L,
Elena C,
Doubek M,
Steurer M,
Tosic N,
Pavlovic S,
Guglielmelli P,
Pieri L,
Vannucchi AM,
Gisslinger H,
Cazzola M,
Kralovics R.
Am J Hematol. 2012 Mar;87(3):245-50. doi: 10.1002/ajh.22257. Epub 2011 Dec 21.
2012
Viral immune modulators perturb the human molecular network by common and unique strategies.
Pichlmair A,
Kandasamy K,
Alvisi G,
Mulhern O,
Sacco R,
Habjan M,
Binder M,
Stefanovic A,
Eberle CA,
Goncalves A,
Bürckstümmer T,
Müller AC,
Fauster A,
Holze C,
Lindsten K,
Goodbourn S,
Kochs G,
Weber F,
Bartenschlager R,
Bowie AG,
Bennett KL,
Colinge J,
Superti-Furga G.
Nature. 2012 Jul 26;487(7408):486-90.
2012
Mechanisms of long range silencing by imprinted macro non-coding RNAs.
Pauler FM,
Barlow DP,
Hudson QJ.
Curr Opin Genet Dev. 2012 Jun;22(3):283-9. Epub 2012 Mar 3.
2012
The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors.
Papac-Milicevic N,
Breuss JM,
Zaujec J,
Ryban L,
Plyushch T,
Wagner GA,
Fenzl S,
Dremsek P,
Cabaravic M,
Steiner M,
Glass CK,
Binder CJ,
Uhrin P,
Binder BR.
Circulation Research. 2012 Apr 13;110(8):e50-63.
2012
Clinical significance of genetic aberrations in secondary acute myeloid leukemia.
Milosevic JD,
Puda A,
Malcovati L,
Berg T,
Hofbauer M,
Stukalov A,
Klampfl T,
Harutyunyan AS,
Gisslinger H,
Gisslinger B,
Burjanivova T,
Rumi E,
Pietra D,
Elena C,
Vannucchi AM,
Doubek M,
Dvorakova D,
Robesova B,
Wieser R,
Koller E,
Suvajdzic N,
Tomin D,
Tosic N,
Colinge J,
Racil Z,
Steurer M,
Pavlovic S,
Cazzola M,
Kralovics R.
Am J Hematol. 2012 Nov;87(11):1010-6.
2012
Genetic and epigenetic alterations of myeloproliferative disorders.
Milosevic JD,
Kralovics R.
Int J Hematol. 2012 Dec 12. [Epub ahead of print].
2012
DNA methylation biomarkers in cancer: progress towards clinical implementation.
Mikeska T,
Bock C,
Do H,
Dobrovic A.
Expert Review of Molecular Diagnostics. Expert Rev Mol Diagn. 2012 Jun;12(5):473-87.
2012
Erosion of Dosage Compensation Impacts Human iPSC Disease Modeling.
Mekhoubad S,
Bock C,
Egli D,
De Boer S,
Kiskinis E,
Meissner A,
Eggan K.
Cell Stem Cell 2012 May 4;10(5):595-609.
2012
Abrogated transforming growth factor beta receptor II (TGF_RII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.
Lievens D,
Habets KL,
Robertson AK,
Laouar Y,
Winkels H,
Rademakers T,
Beckers L,
Wijnands E,
Boon L,
Mosaheb M,
Ait-Oufella H,
Mallat Z,
Flavell RA,
Rudling M,
Binder CJ,
Gerdes N,
Biessen EA,
Weber C,
Daemen MJ,
Kuiper J,
Lutgens E.
Eur Heart J. 2012 May 21.
2012
Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing.
Latos PA,
Pauler FM,
Koerner MV,
_energin HB,
Hudson QJ,
Stocsits RR,
Allhoff W,
Stricker SH,
Klement RM,
Warczok KE,
Aumayr K,
Pasierbek P,
Barlow DP.
Science. 2012 Dec 14;338(6113):1469-72.
